Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-01-04 @ 10:02 AM
Study NCT ID:
NCT02162056
Status:
COMPLETED
Last Update Posted:
2020-04-28
First Post:
2014-06-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold
Sponsor:
University of Ulm
Organization:
Study Overview
Official Title:
Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CSI-Ulm-BVS
Brief Summary:
To evaluate the safety, performance and efficacy of the bioresorbable vascular scaffold (BVS) system in patients with coronary artery disease
Detailed Description:
Patients with coronary artery disease receive bioabsorbable vascular scaffolds. Patients are clinically followed during a period of 10 years.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: